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Abstract
Background: Thousands of different long non-coding RNAs are expressed during embryonic development, but the
function of these molecules remains largely unexplored.
Results: Here we characterize the expression and function of Six3OS, a long non-coding RNA that is transcribed
from the distal promoter region of the gene encoding the homeodomain transcription factor Six3. Overexpression
and knockdown analysis of Six3OS reveals that it plays an essential role in regulating retinal cell specification. We
further observe that Six3OS regulates Six3 activity in developing retina, but does not do so by modulating Six3
expression. Finally, we show that Six3OS binds directly to Ezh2 and Eya family members, indicating that Six3OS can
act as a molecular scaffold to recruit histone modification enzymes to Six3 target genes.
Conclusions: Our findings demonstrate a novel mechanism by which promoter-associated long non-coding RNAs
can modulate the activity of their associated protein coding genes, and highlight the importance of this diverse
class of molecules in the control of neural development.
Background
It has recently become clear that long non-coding RNAs
(lncRNAs) comprise a large fraction of the mammalian
transcriptome [1]. Much effort has been focused on func-
tional analysis of lncRNAs that are processed into short
fragments, such as microRNAs, that regulate expression
of protein coding genes via homologous base pairing.
However, several thousand mammalian lncRNAs have
been identified that span multiple kilobases in length,
and in some cases show extensive conservation at the
nucleotide level [2-4].
To date, only a small number of lncRNAs have been
functionally characterized, although this list is growing
rapidly. Some lncRNAs act via antisense base pairing to
block gene expression [5-7], but many show no clear
sequence overlap with the mRNAs of protein coding
genes. Several of these lncRNAs are known instead to
regulate mRNA transcription, acting in cis to regulate het-
erochromatin formation at nearby genomic loci. The Xist/
Tsix transcripts mediate X-inactivation in placental mam-
mals [8], and Kcnq1ot is important for silencing of the
Kcnq locus resulting from parental imprinting [9]. Other
lncRNAs regulate transcription of genes that are located
great distances away from their own genomic loci. One
notable example of such a trans-acting lncRNA is
HOTAIR, which is transcribed from within specific Hox
gene clusters, but which regulates the expression of Hox
genes located on different chromosomes [10,11]. HOTAIR,
Kcnq1ot and Xist all mediate their effects by interacting
with the Polycomb-repressive complex 2 (PRC2) compo-
nent Ezh2 (enhancer of zeste homolog 2 (Drosophila)) and
modulating histone methylation [9,11,12]. Finally, a small
number of lncRNAs also directly interact with transcrip-
tion factors, and potentially function as transcriptional
coregulators [13-15]. Although the emerging picture sug-
gests that lncRNAs may play an important and widespread
role in regulating mammalian gene expression, a central
and still unresolved question is how lncRNAs act in trans
to regulate expression of specific target genes without the
use of homologous base paring.
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developing and mature mammalian central nervous
system, with the cellular expression patterns of nearly 1,
000 different lncRNAs having been previously described
[16-18]. Many show highly specific expression in specific
brain regions and neuronal subtypes and it has been
s p e c u l a t e dt h a tt h e s el n c R N A sm a yp l a yac r i t i c a lr o l e
in generating and maintaining the great cellular com-
plexity found in the central nervous system [19,20].
Although a limited number of intergenic lncRNAs have
been found to regulate neural development, their mode
of action remains obscure [21,22]. Mechanistic insight
into the function of one brain-expressed lncRNAs has
come from analysis of Evf-2, a lncRNA co-transcribed
with the homeodomain factor Dlx6. Evf-2 modulates
transcription of Dlx6 by recruiting DLX2 and MECP2 to
the ultraconserved ei enhancer element that is also tran-
scribed as part of Evf-2 itself. The transcribed domain
containing the ei sequence is essential for Evf-2 to acti-
vate expression of Dlx6, which has raised the possibility
that Evf-2 might regulate Dlx6 transcription at least in
part through the formation of a RNA-DNA hybrid; this
hybrid may in turn facilitate binding of the ei sequence
by DLX2 and MECP2 [14,15].
Recent studies have also begun to address the function
of long non-coding opposite-strand transcripts (lncOSTs),
which are divergently co-transcribed with a broad range of
neuronally expressed genes. Over one-third of brain-
expressed homeodomain genes possess an associated
lncOST, which typically spans the promoter, but not the
transcribed region, of the protein coding gene in question
[23,24]. Since short promoter-associated ncRNAs can reg-
ulate expression of nearby protein coding genes [25-27],
this has raised the possibility that these lncOSTs might
also act in cis to selectively regulate the expression of their
associated protein coding gene. However, although
lncOSTs comprise a substantial fraction of all brain-
expressed lncRNA species, their function has yet to be
directly investigated.
In this study, we characterize the molecular function and
mechanism of the lncOST Six3OS. Six3OS is co-expressed
with the homeodomain factor Six3, a homologue of the
Drosophila sine oculis gene [28,29]. Like sine oculis, Six3
plays a critical role in mammalian eye development, regu-
lating both early eye formation and cell specification in the
postnatal retina [30,31]. Both Six3 and Six3OS are strongly
and selectively expressed in the developing mouse retina
and hypothalamus [23,32,33]. We use both in vivo overex-
pression and short hairpin RNA (shRNA)-mediated
knockdown analysis to analyze whether gain or loss of
function of Six3OS results in altered differentiation of spe-
cific retinal cell subtypes. We also examine whether
Six3OS acts cooperatively with Six3 to regulate retinal dif-
ferentiation, but find that Six3OS does not regulate Six3
expression levels. Finally, we provide evidence that Six3OS
can directly bind both to known transcriptional coregula-
tors of Six3 and to histone modification enzymes, thereby
functioning as an RNA-based transcriptional scaffold.
These results demonstrate the mechanism by which this
diverse class of molecules regulates cell specification dur-
ing development.
Results
Genomic organization of Six3 and Six3OS
To determine which regions of Six3OS to target for func-
tional analysis, we first examined the genomic organiza-
tion and evolutionary conservation of this lncOST using
publicly available cDNA and genomic sequence. As pre-
viously reported, we found that Six3OS is alternatively
spliced in both mouse and human [23], although Six3OS-
like transcripts were not identified in any other vertebrate
species examined (data not shown). To determine which
sequences to target for overexpression and knockdown,
we aligned these sequences and observed that the puta-
tive full-length mouse cDNA BC065087 contains the
exon sequences shared by all alternative splice forms of
Six3OS (Figure 1, light grey bars). Two of these exons are
adjacent to alternatively spliced exons of the human
Six3OS orthologue, which lie within intronic regions of
the mouse transcript (Figure 1, dark grey bars). This
cDNA corresponds to the most abundant isoform in neo-
natal retina as measured by serial analysis of gene expres-
sion (SAGE) tag abundance [32], and also matches the
4.5-kb isoform of Six3OS, previously reported to be the
most abundant isoform expressed in embryonic brain
[33]. We therefore selected this cDNA for analysis by
overexpression.
Cellular expression pattern of Six3OS
To determine if Six3 and Six3OS are co-expressed in ret-
inal progenitors, as had been previously suggested
[23,32,33], we performed chromogenic in situ hybridiza-
tion (ISH) on sections of embryonic day (E)16.5 and
postnatal day (P)0.5 retina (Figure 2A-H). We observed
that Six3 and Six3OS are co-expressed in both retinal
progenitor cells and newly post-mitotic cells of the inner
neuroblastic layer. Additionally, Six3OS is expressed in
the developing lens (Figure 2C), while Six3 expression is
concentrated at the interface of the inner and outer neu-
roblastic layers (Figure 2B) at E16.5. At P0.5, Six3OS
expression appears to be more concentrated in the outer
neuroblastic layer when compared to Six3, which is pri-
marily found in the inner neuroblastic layer (Figure 2H).
The differences at the interface between these layers are
more difficult to discern at P0.5, due to the increased
expression of Six3OS in the outer neuroblastic layer (Fig-
u r e2 E - H ) .T od e t e r m i n et h es ubcellular expression pat-
tern of Six3OS during development, we performed
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Page 2 of 14fluorescent ISH (FISH) with a probe for Six3OS at E14.5,
at which point prominent expression in progenitor cells
of the outer neuroblastic layer is seen (Figure 2I). Inter-
estingly, though most Six3OS RNA is localized in the
cytoplasm of retinal progenitors at this stage, some
Six3OS RNA is also associated with nuclear DNA (Figure
2I, J). This subcellular distribution has also been noted
for the lncRNA Evf-2 [14]. Using FISH in conjunction
with immunostaining for the cytoplasmic ribosomal
protein S6, we observed that the Six3OS transcript is also
found in the nucleus and cytoplasm when expressed in
transfected HeLa cells (Additional file 1).
Overexpression and knockdown of Six3 and Six3OS
Since Six3OS was coexpressed with Six3 in retinal pro-
genitors, we hypothesized that Six3OS might regulate the
expression and/or activity of Six3 in developing retina.
To determine if this was indeed the case, we employed
RNCR1/Six3OS12   BC065087*
Six3OS1 AK044330 
Six3OS4 AK053722 
Six3OS8 AY590888 
Six3OS9 AY590889 
Six3 
86,000,000      86,010,000  86,020,000         
Mouse Chr17 
30-way Multiz  Alignment & Conservation 
Six3 
Six3OS1 BM663835*
Six3OS4 BM690547 
Human Chr2 
45,005,000             45,015,000       45,025,000 
Six3OS2 CN285777 
Six3OS3 BM451513*
Six3OS5 BX115070*
28-way Multiz  Alignment & Conservation 
Six3OS6 BF445141 
Figure 1 Genomic structure and evolutionary conservation of Six3 and Six3OS. Schematic drawing showing conservation of human and
mouse Six3 and Six3OS genomic structure. Light grey bars show where the predominant Six3OS mouse and human forms overlap. Dark grey
bars indicate where mouse Six3OS is adjacent to conserved regions. Conservation is plotted using the PhastCons program [47]. An asterisk
indicates the cRNA probes that were hybridized to the protein microarray in Figure 6.
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Page 3 of 14in vivo electroporation of neonatal (P0.5) mice to deter-
mine whether overexpression and knockdown of Six3OS
phenocopied the effects of overexpression and knock-
down of Six3. For overexpression of Six3OS,w eu s e d
full-length cDNAs corresponding to BC065087 (Figure 1)
cloned into the pCAG plasmid [34]. Upon transfection
into HeLa cells, robust Six3OS expression was confirmed
by FISH (Additional file 1). To visualize electroporated
cells, all constructs were co-electroporated with plasmids
expressing green fluorescent protein (GFP) from the
same CAG promoter.
We observed that overexpression of 1 μgo fSix3OS
resulted in no significant change in any major retinal
cell type, and section immunohistochemistry revealed
that electroporated cells showed grossly normal mor-
phology (Figure 3B, C, white arrowheads). However,
when dissociated cell preparations were examined, a
significant decrease (P < 0.05) in the fraction of
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Figure 2 Expression and subcellular localization of Six3OS and Six3 in the developing retina. (A-H) Analysis of adjacent sections using
chromogenic ISH for Six3OS and Six3 indicates substantial overlap of Six3OS and Six3 expression at E16.5 (A-D) and P0.5 (E-H). (I, J) Section
fluorescent in situ hybridization (FISH) showing Six3OS expression. At E14.5, Six3OS is localized in both the nucleus (crosshairs) and the cytoplasm
(I).
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Page 4 of 14GFP-positive cells expressing amacrine cell-specific mar-
ker syntaxin was observed relative to cells electroporated
with the GFP control vector at P21 (Figure 3A). Since
Six3OS overexpression did not alter the fraction of GFP-
positive cells with amacrine-like morphology and lami-
nar position, we conclude that Six3OS does not inhibit
amacrine cell specification. The reduction in syntaxin
expression seen following CAG-Six3OS electropora-
tion thus reflects a quantitative reduction in syntaxin
levels or possibly reflects reduced adhesion of Six3OS-
expressing amacrine cells following dissociation for
immunocytochemistry.
Figure 3 Overexpression of Six3OS in developing retina inhibits changes in cell fate and photoreceptor morphology observed
following Six3 overexpression. (A) Electroporation of CAG-Six3 l e dt oa ni n c r e a s ei nt h ef r a c t i o no fG F P - p o s i t i v ec e l l se x p r e s s i n gt h e
amacrine cell marker syntaxin and a decrease in cells expressing the rod bipolar marker PKCa,C A G - Six3OS led to a decrease in syntaxin-
positive cells, and co-expression led to a cell composition that was indistinguishable from CAG-GFP controls. *P < 0.05. (B-E) Section
immunohistochemistry of retinas electroporated with CAG-GFP, CAG-Six3OS,C A G - Six3 or both CAG-Six3OS and CAG-Six3.W h i t ed a s h e dl i n e s
define the outer third of the outer nuclear layer (OONL). Syntaxin (red) is co-immunostained with GFP (green). (C) No obvious difference is
observed in either amacrine cell number or morphology (white arrowheads) in retinas electroporated with CAG-Six3OS relative to CAG-GFP
controls or in the fraction of the cells in the OONL. (D) An increase in amacrine cell number and in the number of cells in the OONL and a
decrease in outer segment length is observed in the case of Six3. (E) An increase in the number of cells in the OONL is observed, but no
difference in amacrine cell number or outer segment length is observed from controls following co-electroporation of CAG-Six3 and CAG-
Six3OS. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer segment.. (F) Laminar position of cells within
the OONL. Electroporation of CAG-Six3 leads to a shift of rod photoreceptor cell bodies to the OONL, and this effect is not affected by co-
electroporation of CAG-Six3OS (white dashed lines in B-E). (G) Rod photoreceptors electroporated with CAG-Six3 show substantially
shorter outer segments and this effect is reversed by co-electroporation with CAG-Six3OS. Cell type specific markers used: rhodopsin (Rho4D2),
rod photoreceptors; glutamine synthetase (GS), Muller glia; protein kinase C alpha (PKCa), rod bipolar cells; syntaxin (Syn), amacrine cells.
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Six3 using in vivo electroporation. Upon electroporation,
expression of Six3 was confirmed by section immuno-
histochemistry. Cell fate specification in the postnatal
retina is highly sensitive to Six3 dosage, and both gain
and loss of function of Six3 have been reported to result
in similar defects in bipolar cell and photoreceptor
development [30]. We observed that electroporation of
1 μgo fp C A G - Six3 led to a reduction in the number of
rod bipolar cells, and detected an increase in the frac-
tion of GFP-positive amacrine cells by P21 (P < 0.05;
Figure 3A, D). The length of the outer segments of
GFP-positive rod photoreceptors was also decreased
(P < 0.05; Figure 3D, G). Finally, we observed that the
cell bodies of the Six3 electroporated photoreceptor
cells were primarily located in the outer third of the
outer nuclear layer (P < 0.05; Figure 3D, white dashed
line, and 3F), in contrast to photoreceptors electropo-
rated with control vector, which were distributed
throughout the outer nuclear layer.
We then analyzed the effects of loss of function of
Six3OS and Six3.T ot h i se n d ,w ef i r s tt e s t e ds h R N A s
for their ability to reduce expression of endogenous Six3
and Six3OS expression by in vivo electroporation of P0.5
retina. Reduction in expression of the target gene was
determined by analyzing expression of either Six3 pro-
tein or Six3OS RNA dissociated GFP-positive cells. For
both Six3 and Six3OS, individual shRNA constructs
were identified that resulted in a substantial reduction
in the average fluorescence intensity in either Six3 pro-
tein or Six3OS RNA in GFP-positive cells (Additional
file 2).
A significant decrease in the fraction of protein kinase C
a (PKCa) positive rod bipolar cells was observed at P21
following electroporation of either 1 μgo fSix3 shRNA
construct or 1 μgo fSix3OS shRNA (P < 0.05; Figure 4A),
reminiscent of effects of retroviral overexpression of a
dominant-negative mutant form of Six3 [30]. The fraction
of glutamine synthetase-positive Muller glia was also
increased (P < 0.05; Figure 4A). Section immunohisto-
chemistry confirmed an increase in glutamine synthetase-
positive cells with Muller glia-like morphology, at the
expense of cells expressing the bipolar cell marker CHX10
and demonstrating bipolar-like morphology (Figure 4B-D,
Figure 4 shRNA-mediated knockdown of Six3 and Six3OS in the developing retina alters bipolar cell and Muller glial development. (A)
Six3 knockdown and Six3OS knockdown both lead to an increase in Muller glia and a decrease in rod bipolar cells as measured by
immunostaining of dissociated electroporated retinal cells. Simultaneous knockdown of both Six3 and Six3OS resulted in a normal number of rod
bipolar and Muller glia, but a decrease in syntaxin (Syn)-positive amacrine cells was observed. *P < 0.05. GS, glutamine synthetase. (B-E) Section
immunohistochemistry demonstrates a decrease in GFP-positive bipolar cells following knockdown of either Six3OS or Six3, but not both in
combination (white arrowheads). Chx10 (ceh-10 homeodomain containing homolog (C. elegans)) was used as pan-bipolar cell marker. GCL,
ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer segment.
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Page 6 of 14white arrowheads). To further confirm that knockdown
experiments did indeed result in a selective loss of func-
tion of Six3OS, we also inhibited Six3OS function by over-
expression of Six3OS-IRES-GFP. Fusion of IRES-GFP to
lncRNAs results in a mislocalization of lncRNAs to the
ribosome, and can produce dominant negative phenotypes
when overexpressed [22]. When this is performed, we
observed a reduction in rod bipolar markers and an
increase in Muller markers, phenocopying the effects of
Six3OS knockdown (data not shown).
Simultaneous overexpression and knockdown of Six3 and
Six3OS demonstrates non-additive effects on retinal
differentiation
Having observed that loss of function of Six3 and Six3OS
resulted in similar phenotypes in developing retina, we
next investigated whether these two genes acted coopera-
tively or independently to regulate retinal differentiation.
We first used in vivo electroporation to overexpress 1 μg
of both the Six3 and Six3OS constructs simultaneously in
P0.5 retina. We observed that co-expression of Six3 and
Six3OS resulted in a normal cell fate phenotype (Figure
3A). The length of GFP-positive rod photoreceptor outer
segments was indistinguishable from controls (Figure 3B,
E, G). However, the cell bodies of the electroporated
photoreceptor cells were primarily located in the outer
third of the outer nuclear layer (P <0 . 0 5 ;F i g u r e3 B ,E ,
white dashed line, and 3F). We thus concluded that over-
expression of Six3OS was largely able to reverse the cellu-
lar phenotypes observed following overexpression of Six3.
As a follow up to these experiments, we simultaneously
reduced expression of Six3 and Six3OS by co-electropor-
ating 1 μgo ft h eSix3 shRNA construct and 1 μgo f
Six3OS shRNA construct. We observed that simulta-
neous knockdown of both Six3 and Six3OS resulted in a
normal number of bipolar cells and Muller glia. However,
we observed a significant decrease in the fraction of GFP-
positive amacrine cells, which was not observed following
electroporation of either the Six3 or Six3OS shRNA
alone (P <0 . 0 5 ;F i g u r e4 A ,E ) .T h e s ed a t as h o wan o n -
additive effect of simultaneous loss of function of both
Six3 and Six3OS, and show that these genes functionally
interact to regulate retinal differentiation.
Lastly, we directly investigated the functional relation-
ship between Six3 and Six3OS in vivo by simultaneously
overexpressing Six3 and knocking down Six3OS, and vice
versa. When we co-electroporated 1 μg of CAG-Six3 with
1 μgo fSix3OS shRNA, we found that Six3 overexpression
fully rescued the Six3OS knockdown phenotype. Further-
more, loss of function of Six3OS fully eliminated the
effects of Six3 overexpression. No differences in the com-
position of GFP-positive cells were observed when com-
pared to controls (Figure 5A). Both the morphology and
distribution of the cells within the retina were normal
(Figure 5C, D; Additional file 3A), and the rod photorecep-
tor outer segment length was normal (Additional file 3B).
We conclude that Six3OS is required for many of the
effects on retinal differentiation that result from Six3
overexpression.
In contrast, when 1 μgo fC A G - Six3OS was co-elec-
troporated with 1 μgo fSix3 shRNA, we observed an
increase in glutamine synthetase-positive cells with Mul-
ler glia-like morphology (P < 0.05; Figure 5B) and a
decrease in PKCa-positive and CHX10-positive bipolar
cells (P < 0.05; Figure 5B, C, E) when compared to con-
trols. Additionally, a decrease in cells expressing the
amacrine cell-specific marker syntaxin was observed
(P < 0.05; Figure 5B). These retinas, however, do not
show any change in the number of GFP-positive cells
with amacrine cell-like morphology. We therefore con-
clude that, as is the case when Six3OS alone was overex-
pressed, Six3OS overexpression in conjunction with
knockdown of Six3 reduces syntaxin expression without
otherwise affecting amacrine cell differentiation (Figure
5B, E). The phenotype seen here is the sum of the phe-
notypes seen following Six3OS overexpression and Six3
knockdown, and stands in contrast to the non-additive
phenotype seen when Six3OS and Six3 are both simulta-
neously knocked down (Additional file 4). We thus con-
clude that the phenotype observed following Six3OS
overexpression is not affected by Six3 loss of function,
and that Six3OS may also regulate syntaxin expression
through a Six3-independent mechanism.
Six3OS does not directly regulate Six3 protein levels
Although these data suggest that Six3OS regulates Six3
function in developing retina, they do not directly address
the molecular mechanism by which Six3OS is able to do
so. A number of studies have suggested that both promo-
ter and enhancer-associated lncRNAs can act in cis to reg-
ulate expression levels of nearby protein-coding genes
[14,25-27,35,36]. To investigate whether Six3OS might be
regulating Six3 function by a similar mechanism, we over-
expressed and knocked down expression of Six3OS at P0.5
in retina, and quantified the level of Six3 protein in GFP-
positive cells at P5.5. We did not observe any change in
Six3 protein levels following either overexpression or
knockdown of Six3OS (Additional file 5A, B). Further-
more, we tested whether Six3OS could regulate Six3-
dependent regulation of a reporter construct derived from
the sequence of the mouse Six3 promoter, which was pre-
viously shown to be negatively regulated by Six3 [30]. To
determine if Six3OS modulates Six3-mediated auto-repres-
sion, CAG-Six3OS was cotransfected with the CMV-Six3
and the Six3-pro luciferase vector. As previously reported,
overexpression of Six3 represses this reporter construct
when tested in NIH3T3 cells. However, Six3OS overex-
pression had no effect on Six3-mediated auto-repression
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mouse cell lines were tested, no Six3OS-dependent effects
on Six3-mediated autorepression could be detected (data
not shown). We conclude that transcription of Six3
mRNA is not regulated by Six3OS. Instead Six3OS RNA
likely modulates the ability of Six3 protein to activate or
repress expression of its target genes in developing retinal
cells.
Ezh2 and Eya1/3/4 directly bind Six3OS
To identify proteins that directly bind Six3OS,C y 5 -
labeled Six3OS RNA was used to probe human protein
microarrays [37]. Mouse Six3OS and three human splice
variants of Six3OS were transcribed in vitro and labeled
with Cy5, and antisense cRNAs for these same tran-
scripts were hybridized in parallel as negative controls.
A total of five proteins that specifically and selectively
interact with both the mouse and human forms of
Six3OS were thus identified. We found that both human
and mouse Six3OS selectively interact with Eya1,
encoded by a homologue of the eyes absent gene of Dro-
sophila. In addition, Six3OS directly binds to the
chromatin remodeling enzyme subunits Smarce1 and
Ezh2, as well as Eno1 and Ppp5c (Additional file 7).
Members of the Eya protein family have been previously
shown to interact with Six family proteins [38], but Eya1
is not expressed in the mouse neuroretina [32]. There-
fore, we also performed RNA immunoprecipitation
(RIP) experiments on Eya3 and Eya4, which are both
robustly expressed in embryonic retina.
To test whether Ezh2 and Eya family members inter-
act with mouse Six3OS in vivo, co-immunoprecipitation
experiments were performed in HEK 293T cells overex-
pressing V5-tagged Eya1, Eya3, Eya4 and Ezh2. Expres-
sion and immunoprecipitation of V5-tagged protein was
verified by immunoblot (Additional file 8). We con-
firmed that mouse Six3OS RNA selectively interacts
with each of these proteins using RIP (Figure 6), and
conclude that these proteins interact with Six3OS in
transfected HEK 293T cells. To confirm that Six3OS
interacts with Eya family members and Ezh2 specifically,
we examined whether Six3OS interacts directly with
Six3 protein by RIP and found that Six3OS and Six3 do
not interact in transfected HEK 293T cells (data not
Figure 5 Six3 overexpression rescues the Six3OS knockdown phenotype whereas Six3OS overexpression is not sufficient to rescue the
loss of Six3. (A) Six3OS knockdown combined with Six3 overexpression led to a cell type distribution indistinguishable from cells electroporated
with control constructs when tested by immunostaining of dissociated electroporated retinal cells. (B) Six3 knockdown combined with Six3OS
overexpression led to an increase in Muller glia and a decrease in rod bipolar cells and a decrease in syntaxin (Syn)-positive amacrine cells. GS,
glutamine synthetase. (C-E) Section immunohistochemistry of retinas confirm a distribution of GFP-positive cells that is indistinguishable from
controls when Six3OS knockdown is combined with Six3 overexpression, while Six3 knockdown and Six3OS overexpression led to a decrease in
bipolar cells (F, white arrowheads). GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer segment.
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tion by facilitating interaction between Eya proteins and
chromatin-modifying enzyme complexes.
Discussion
Six3OS and Six3 modulate retinal cell specification and
differentiation
Our findings demonstrate that both gain and loss of
function of Six3OS and Six3 affect retinal differentiation
(Additional file 4). Knockdown of Six3OS resulted in a
decrease in the fraction of bipolar cells and an increase in
Muller glia in electroporated cells. An identical pheno-
type was observed following knockdown of Six3 (Figure
4). Knockdown of either Six3OS or Six3 phenocopies the
effect of retroviral overexpression of a dominant-negative
form of Six3 in neonatal retina, where a substantial
decrease in bipolar cells was also seen [30].
In contrast, overexpression of either Six3 or Six3OS
alone produced very different phenotypes. Six3OS over-
expression resulted in a reduction in syntaxin staining
in electroporated amacrine cells, but did not alter the
morphology or laminar position of electroporated cells.
On the other hand, Six3 overexpression, like Six3 loss of
function, resulted in a dramatic reduction in the number
of bipolar cells (Figure 3A), and also resulted in
decreased rod photoreceptor outer segment length at
P21 (Figure 3D, G). These effects were previously
reported following retroviral-mediated overexpression of
Six3 [30]. Interestingly, we also observed phenotypes
that were not reported in this previous study, such as an
increase in amacrine cells. A number of technical differ-
ences between these two experiments may account for
these differences, most notably the fact that electropora-
tion-mediated overexpression typically results in much
higher levels of construct expression in developing
retina than does retroviral transduction [34].
Six3OS regulates Six3 activity in developing retina, but
does not regulate Six3 expression levels
If Six3 and Six3OS act independently to control retinal
cell specification, we would expect to observe purely
additive phenotypes when their activities are both
altered. Strikingly, when both Six3OS and Six3 were
overexpressed simultaneously, we no longer observed
the cellular phenotypes thatr e s u l t e df r o mo v e r e x p r e s -
sion of Six3 alone. Simultaneous knockdown of both
Six3OS and Six3 also showed non-additive effects. The
loss of bipolar cells and increase in Muller glia, which
was seen following knockdown of each gene individually,
were not observed when expression of both Six3 and
Six3OS was reduced. Instead, a decrease in amacrine
cells was observed, which was a phenotype not observed
when each individual gene was knocked down. These
non-additive phenotypes demonstrate an epistatic rela-
tionship between Six3 and Six3OS,a n di m p l yt h a tt h e y
functionally interact to regulate retinal differentiation.
Having demonstrated that Six3 and Six3OS interact to
regulate retinal differentiation, we next investigated
whether defects in Six3 could be rescued by overexpres-
sion of Six3OS,a n dvice versa.W h e nSix3 is overexpressed
but Six3OS is knocked down, none of the phenotypes nor-
mally seen following either Six3 overexpression alone or
Six3OS knockdown alone were observed (Figure 5A, C-D).
These data indicate that loss of function of Six3OS sup-
presses the effects of both gain and loss of function of
Six3. However, simultaneous overexpression of Six3OS
and knockdown of Six3 resulted in a purely additive phe-
notype that was the sum of the effects of Six3 knockdown
and Six3OS overexpression. These findings suggest that
Six3OS acts to regulate Six3 activity, since overexpression
of Six3 can rescue the effects of Six3OS knockdown, but
not vice versa.A sSix3OS overexpression leads to a reduc-
tion in syntaxin expression even following Six3 knock-
d o w n ,t h i si m p l i e st h a tSix3OS may also regulate retinal
differentiation through a Six3-independent mechanism,
although this remains to be characterized further.
Since both promoter- and enhancer-associated
ncRNAs have been previously thought to act in cis to
selectively regulate expression of nearby protein coding
genes [36,39], our finding that Six3OS did not regulate
Six3 expression came as something of a surprise. Our
finding that Six3OS acts in trans to regulate retinal differ-
entiation was supported by several lines of evidence.
First, by the finding that the activity of Six3 expressed
from the CAG promoter can be modulated by overex-
pression or knockdown of Six3OS (Figure 5). Second, we
have directly demonstrated that neither overexpression
nor knockdown of Six3OS has any detectable effect on
Six3 expression in retina, nor does Six3OS have an effect
on Six3-dependent autorepression when measured by
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Mean ± standard deviation, n = 3, relative to input is shown.
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These data imply that Six3OS and perhaps other lncOSTs
do not regulate transcription of their associated protein
coding genes, but instead act in trans to regulate the
activity directly via protein-RNA interactions. This
mechanism may not hold true for all promoter-associated
lncRNAs, however, and each will have to be characterized
independently to determine its mechanism of action.
Six3OS selectively interacts with Eya family members and
Ezh2
While these data demonstrate a functional relationship
between Six3OS and Six3, they still leave the precise
mechanism by which Six3OS regulates Six3 activity unre-
solved. Our finding that both human and mouse isoforms
of Six3OS interact with multiple different members of the
eyes absent protein family demonstrates how this might
occur in vivo. The eyes absent (eya) gene and its mamma-
lian homologues encode protein tyrosine phosphatases
that function as transcriptional coregulators. Eya binds
directly to sine oculis, and acts in conjunction with sine
oculis in controlling eye field specification in Drosophila
[28,29]. We also observe that Six3OS directly binds the
PRC2 subunit Ezh2, and also possibly the BAF57 subunit
Smarce1. Additional confirmation that Six3OS interacts
with Ezh2 in vivo comes from a recent study of poly-
comb-associated RNAs, which found that Six3OS was co-
precipitated with PRC2 in embryonic stem cells [40]. We
propose that Six3OS can modulate the expression of Six3
target genes without necessarily regulating expression of
Six3 itself by acting as a transcriptional scaffold. When
Six3 directs the Six3-Eya complex to bind to specific
genomic target sequences, Six3OS may thus act as a tran-
scriptional scaffold, recruiting histone modifying enzyme
complexes to regulate expression of Six3 target genes.
Although trans-acting lncRNAs have previously been
found to regulate gene expression through recruitment of
the Ezh2-containing PRC2 histone methyltransferase
complex, their action is restricted to a small subset of tar-
get genes, and the mechanism by which this occurs is
unknown [11]. Our findings point towards a plausible
mechanism by which this could occur. However, in the
absence of RNA-IP data that clearly demonstrate interac-
tion of Six3OS with both Eya proteins and Six3 in devel-
oping retina, other potential mechanisms of action of
Six3OS remain plausible.
Several unresolved questions remain, the most obvious
being which Eya subtype is the most relevant target of
Six3OS in vivo. Eya1 is known to bind Six3 both in vitro
and in transfected tissue culture cells [41], although the
co-expression of Six3 and Eya1 is limited to the ciliary
margin and lens [42]. Eya2, Eya3 and Eya4, however, are
all co-expressed with Six3 and Six3OS in both the devel-
oping retina and in other forebrain regions [42]. Eya4
and Six3 have been demonstrated to interact in a study
of holoprosencephaly, indicating that Eya4 may be the
functional bridge between Six3 and Six3OS in the devel-
oping ventral forebrain [43]. Our findings indicate that
Six3OS may also regulate retinal differentiation by Six3-
independent mechanisms. Since Eya family members can
interact with other classes of transcription factors,
including Hox and Tlx family members [44], this sug-
gests that Six3OS might also modulate the expression of
genes regulated by these transcription factors.
Many homeodomain transcription factors that are
essential for central nervous system development possess
an associated lncOST, including Pax6, Rax, Vax2 and Six6
[23,45]. Each of these proteins exhibits complex and
dynamic expression during development, and their expres-
sion patterns often diverge considerably from those of
their associated lncOST. Although their target sequences
are present in all cells, the genes that are directly regulated
by each protein can vary considerably, both at different
developmental stages and in different cell types. Models
that explain how this context-dependent regulation of
transcription factor activity occurs have typically empha-
sized combinatorial regulation by other proteins, or cell-
and stage-specific epigenetic modifications. Our finding
that lncOSTs can modulate the activity of their associated
transcription factors lends an additional layer of complex-
ity to these models, and suggests that this diverse class of
molecules may play a critical function in generation of cell
subtype diversity within the developing central nervous
system.
Materials and methods
Animals
Pregnant CD-1 mice were purchased from Charles River
Breeding Laboratories, Wilmington, MA, USA. Animal
experiments were approved by the Johns Hopkins Uni-
versity Institutional Animal Care and Use Committee.
In vivo electroporation
In vivo electroporation of mouse retina was performed as
described [34]. Retinas were electroporated at P0.5. Dis-
sociated cells and section immunohistochemistry data
shown here were performed at P21. Error bars represent
± standard error of the mean for at least three indepen-
dent electroporated retinas. A two-tailed Students t-test
was performed to determine the P-value. Control and
experimental constructs were co-electroporated with 0.2
μg of pCAG-GFP to readily visualize electroporated cells
by GFP [34]. For overexpression experiments, 1 μgo f
pCAG-GFP was injected with either 1 μgo fp C A G - Six3
or 1 μg of CAG-Six3OS. For simultaneous overexpression
of Six3 and Six3OS, retinas were electroporated with 1 μg
of pCAG-Six3 and 1 μgo fC A G - Six3OS. For knockdown
of Six3 and Six3OS,1μg of U6-control was injected with
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neous knockdown, 1 μgo fU 6 - Six3 and 1 μgo fU 6 -
Six3OS were injected. For overexpression of Six3 in com-
bination with knockdown of Six3OS, retinas were electro-
porated with 1 μgo fp C A G - Six3 and 1 μgo fU 6 - Six3OS
were injected. Finally, for overexpression of Six3OS
in combination with knockdown of Six3,1μgo fp C A G -
Six3OS and 1 μgo fU 6 - Six3 were injected and
electroporated.
In situ hybridization
For cryosections, untimed E14.5 and E16.5 embryos and
P0.5 neonates were dissected, fixed overnight in 4% par-
aformaldehyde in PBS at 4°C and cryoprotected overnight
in 30% sucrose/PBS at 4°C before being embedded in
OCT compound (Sakura, Torrance, CA, USA) on dry ice.
Cryosections (20 μm) were cut on a cryostat. Section ISH
methodology was as previously described [32] with the
exception that probe BC065087 was used and a Tyramide
Signal Amplification system (TSA Plus, Perkin Elmer,
NEL 744, Waltham, MA, USA) combined with an antidi-
goxigenin-HRP antibody (1:1, 000; Roche, Indianapolis,
IN, USA). for fluorescent ISH. Fluorescent ISH sections
were counterstained with DAPI. Fluorescent ISH samples
were photographed on a Zeiss Meta 510 confocal micro-
scope. Chromogenic images were visualized on a Zeiss
Axioskop2 microscope.
Immunohistochemistry
For cryosections, electroporated eyes were harvested 21
days after electroporation, fixed for 1 hour in 4% parafor-
maldehyde in PBS at 4°C and cryoprotected overnight in
30% sucrose/PBS at 4°C before being embedded in OCT
compound (Sakura) on dry ice. Cryosections (20 μm) were
cut on a cryostat. Retinal cryosections were immunos-
tained as described except that sections were post fixed in
4% paraformaldehyde for 5 minutes prior to blocking [21].
Samples were photographed on a Zeiss Meta 510 confocal
microscope.
For cell marker analysis, dissociation and immunos-
taining were performed as described [34] except that reti-
nas were harvested at P21. Samples were visualized and
quantified on a Zeiss Axioskop2 microscope. To quantify
the effects of Six3 knockdown, retinas were electropo-
rated with Six3 shRNA, harvested at P4.5, dissociated,
and immunostained as described above with anti-Six3
and detection with Alexa568 goat anti-guinea pig IgG
and rabbit anti-GFP and detection with Alexa488 goat
anti-rabbit. For Six3 quantification, Six3OS overexpres-
sion and SixOS shRNA electroporated retinas were har-
vested at P5.5, dissociated and immunostained as
described above with anti-Six3 and detection with
Alexa568 goat anti-guinea pig IgG and rabbit anti-GFP
and detection with Alexa488 goat anti-rabbit. Samples
were visualized on a Zeiss Axioskop2 microscope and
signal intensity was quantified with Velocity 4.0 (Perkin
Elmer) software by calculating the average signal inten-
sity per cell and normalized to cell size.
In situ hybridization and immunocytochemistry
For Six3OS knockdown quantification, retinas were har-
vested at P4.5 and dissociated as described above. FISH
was performed as described using TSA Plus Cyanine3
kit (1:125; Perkin Elmer, NEL 744) followed by staining
as described (with rabbit anti-GFP and detection with
Alexa488 goat anti rabbit). Samples were visualized and
quantified as above. For all dissociations, nuclear DNA
was visualized with DAPI counterstaining. Cell counts
were analyzed using the two-tailed Student’s t-test. A
minimum of three retinas were counted for each con-
struct examined using dissociated immunocytochemis-
try, with 100 to 300 GFP-positive cells per retina
counted for each marker tested.
HeLa cell FISH followed by immunocytochemistry was
performed as previously described [22] except that 20
cells were counted.
Luciferase reporter assays
NIH 3T3 cells were grown in DMEM supplemented with
10% FCS. Cells were transfected with Fugene6 (Roche) per
the manufacturer’s instructions. Cells were transfected
with 500 ng of luciferase reporter construct and 50 ng of
the expression plasmids for Six3 and Six3OS.C e l l sw e r e
harvested 2 days post-transfection. Luciferase was mea-
sured per manufacturer’s instructions with the Dual-Luci-
ferase Reporter System (Promega, E1910, Madison, WI,
USA). pTK-Renilla (50 ng) was co-transfected to control
for transfection efficiency.
Synthesis of RNA probes for protein microarray
BC065087 (5 μg) was linearized with DraI, and 5 μgo f
BM663835, BX115070, and BM451513 were linearized
with NotI. Linearized DNA was then phenol-chloroform
extracted, ethanol precipitated and resuspended in 10 μl
water. Probes were in vitro transcribed with T7 poly-
merase per manufacturer’s instructions using the Ribop-
robe Combination system kit (Promega, P1405), spiking
the reaction with 1 μl of 5 mM Cy5 labeled CTP (GE
Healthcare, 25-8010-87, Piscataway, NJ, USA). The RNA
probe was ethanol precipitated with LiCl and resus-
pended in 1 mM EDTA.
Protein microarray analysis
Transcription factor/RNA binding protein chips were
generated as previously described [37]. Protein chips
were preblocked with Superblock Buffer (Thermo
Scientific, 37516, Waltham, MA, USA) supplemented
with 10 μgm l
-1 sperm DNA, 2 mM MgCl2,2m gm l
-1
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dized at 250 nM concentration in binding buffer (PBS
supplemented with 2 mM MgCl2, 2 mg ml
-1 BSA) at
room temperature for 1 hour. The slides were washed
four times in TBST, dried and scanned by a GenePix
400B scanner. Data were analyzed with GenePix Pro
6.10 as previously described [46].
RNA immunoprecipitation experiments
HEK 293T cells were grown in DMEM supplemented
with 10% FCS. Cells were transfected with Fugene6
(Roche) per the manufacturer’s instructions. Ten million
cells were transfected 24 hours post-plating with 5 μgo f
pCAGIG-V5, pCAGIG-Six3-V5, pCAGIG Eya1-V5,
pCAGIG Eya3-V5, pCAGIG Eya4-V5 or pCAGIG Ezh2-
V5, and pCAG-Six3OS. Cells were harvested 2 days
post-transfection, lysed and precipitated essentially as
previously described [11], except that 5 μg anti-V5 anti-
body was used (1:5, 000; Invitrogen, R96025, Carlsbad,
CA, USA) with 50 μl protein A-agarose (Invitrogen,
15918-014) in each immunoprecipitation reaction. For
each sample, 10% of total volume was set aside after
lysis for RNA extraction and 5% set aside for immuno-
blot analysis. After precipitation, 80% of the beads were
resuspended in Trizol and 20% were resuspended in
Laemmle buffer. RNA was Trizol extracted and resus-
pended in 50 μl of nuclease free water. RNA was then
DNAse treated with Turbo DNA-free (Ambion,
AM1907, Carlsbad, CA, USA) per manufacturer’s
instructions. RNA was quantified by quantitative RT-
PCR using Brilliant II SYBR Green QRT_PCR Master
Mix (Agilent, 600825, Santa Clara, CA, USA) on a
Roche LightCycler480. No-RT controls were simulta-
neously performed to demonstrate that signal was not
from DNA contamination.
Expression of V5-tagged protein was confirmed by
western analysis using anti-V5 antibody (1:10, 000; Invi-
trogen, R96025) dilution in 5% milk in PBST, and
detected with horse radish peroxidase goat anti-mouse
IgG (1:10, 000; Santa Cruz, sc-2031, Santa Cruz, CA,
USA) and ECL Western Blotting Detection System (GE
Healthcare, RPN2132 Piscataway, NJ, USA) per the man-
ufacturers’ instructions.
Full details of all plasmids and antibodies used in this
study are included in Additional File 9.
Additional material
Additional file 1: Six3OS is localized equally in the nucleus and
cytoplasm. HeLa cells were transfected with Six3OS constructs and RNA
location was analyzed by FISH followed by immunohistochemistry
against the cytoplasmic S6 ribosomal protein. Cytoplasmic Six3OS RNA
was identified by localization with S6 protein. The relative proportion of
nuclear Six3OS, defined as FISH signal that did not colocalize with S6
protein, is indicated. N = 20 cells.
Additional file 2: Confirmation of shRNA-mediated knockdown of
endogenous Six3 and Six3OS in developing retina. (A-E) A construct
encoding either control hairpin, Six3 targeted hairpin or Six3OS targeted
hairpin was electroporated in vivo, into P0.5 retina and harvested at P4.5,
and dissociated, and immunocytochemistry against Six3 and GFP, or FISH
against Six3OS was performed followed by immunostaining for GFP. GFP-
positive cells were counted to analyze the fluorescence intensity for each
cell that expressed (A) Six3 or (D) Six3OS. At least 100 GFP-positive cells
from three different electroporated retinas were counted for each
construct tested. Error bars represent standard error for at least three
independent retinas. (A) P < 0.05; (D) P < 0.05. (B-E) Examples of
dissociated cells positive for GFP and either Six3 protein or Six3OS RNA.
Additional file 3: Six3OS knockdown rescues changes in retinal cell
morphology and position observed following overexpression of
Six3. (A, B) Six3OS knockdown combined with Six3 overexpression
rescues the effects observed on rod photoreceptor cell body position (A)
and on photoreceptor outer segment length observed with Six3
overexpression (B).
Additional file 4: Summary of overexpression and knockdown data
for Six3 and Six3OS. These results demonstrate that co-expression of
Six3OS and Six3 rescues the phenotypes observed with Six3
overexpression except that the photoreceptors are displaced in the outer
third of the outer nuclear layer. Simultaneous knockdown of Six3OS and
Six3 results in a novel phenotype, fewer amacrine cells. Additionally,
Six3OS overexpression rescues the phenotype of knockdown of Six3.
However, expression of Six3 combined with knockdown of Six3OS results
in an additive phenotype.
Additional file 5: Cellular levels of Six3 protein are not affected by
overexpression or knockdown of Six3OS. (A) Overexpression of Six3OS
at P0.5 does not affect Six3 protein levels when measured at P5.5. (B)
shRNA-mediated knockdown at P0.5 of Six3OS does not affect Six3
protein levels when measured at P5.5
Additional file 6: Autorepression of Six3 is not affected by Six3OS.
Transfection of CMV-Six3 together with the Six3-pro luciferase reporter
into NIH 3T3 led to > 70% reduction in luciferase expression. Co-
transfection of CMV-Six3 and CAG-Six3OS with the Six3-pro luciferase
reporter was not significantly different than CMV-Six3 alone.
Additional file 7: List of proteins that interact with the mouse and
human forms of Six3OS from the transcription factor/RNA binding
protein microarray.
Additional file 8: V5 expression constructs are expressed in HEK
293T cells. aV5 western analysis demonstrating that Eya1-V5, Eya3-V5,
Eya4-V5 and Ezh2-V5 are expressed.
Additional file 9: Supporting Information. Includes plasmid
information, shRNA sequences and antibodies used.
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